BioAscent
Newhouse
About BioAscent
BioAscent, based at the former Organon / MSD R&D site in Newhouse, Scotland, UK, is a leading provider of integrated drug discovery services, including de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry, and compound management, all with access to in-house diversity and fragment libraries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Last round: Series Unknown (Jul 2018)
- Website: bioascent.com
- Phone: +44 (0) 1698 534002
Industries & Categories
Automotive, Logistics, Transportation
Social Profiles
Canonical: https://fsome.com/organization/bioascent-111011 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.